<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-03-27" id="root" itemid="473527" xml:lang="en">
<title>UK: Zeneca to buy rest of Salick Health.</title>
<headline>Zeneca to buy rest of Salick Health.</headline>
<dateline>LONDON 1997-03-27</dateline>
<text>
<p>British pharmaceuticals group Zeneca Group Plc said on Thursday it planned to complete its acquisition of U.S. group Salick Health Care Inc by April 10.</p>
<p>Zeneca, which already owns 50 percent of Salick, said it had the right to require Salick to redeem callable puttable common stock. It said the cost for the remaining shares was around $234 million.  </p>
<p>Zeneca said it had paid $204 million for the initial 50 percent stake in Salick.</p>
<p>It said Salick treats patients with catastrophic illness, such as cancer or kidney failure, requiring long-term care.</p>
<p>-- London Newsroom +44 171 542 4017</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-03-27" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-03-27" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="LONDON" />
<dc element="dc.creator.location.country.name" value="UK" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>